Vukojevic et al., 2018), produced by amputation, and/or anti-coagulants application, or major vessel occlusion, along with the evidence that pentadecapeptide BPC 157 may prevent and/or attenuate or eliminate, thus, counteracting both arterial thrombosis (Hrelec et al., 2009
PlexusDx works exclusively with licensed 503A compounding pharmacies that maintain rigorous quality assurance, ingredient verification, and sterility protocols
At Gala Health, we believe access to GLP-1 care should come with real clinical support, not just a prescription
Questions Patients Should Ask a Peptide Provider Before beginning treatment, patients may want to ask: What medical condition or symptom is this intended to address
NTR1 levels are significantly decreased in the hippocampus of cognitively impaired rats and AD patients [64, 65]
Sharps Container: For safe disposal of tools